| PLATINUM |
|
Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes We’re working to meet the needs of health care practitioners and their patients Our in-depth knowledge of non-opioid pain management, coupled with our passion for delivering improved patient care, drives our commitment to providing solutions that address unmet medical needs. |
| PLATINUM |
|
At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. As such, we see huge opportunities to make a difference through innovation, design, and sustainability – partnering with our healthcare customers to increase productivity and deliver better care for more people through our innovation platforms of monitoring, imaging, interventional and enterprise informatics. As a technology brand that cares about people and the planet, we listen, discover and challenge, in order to deliver meaningful innovation to people. |
| GOLD |
|
Our mission is to improve the lives of patients by developing novel, best-in-class treatments to address some of the most important unmet patient needs. We aim to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology. |
| GOLD |
|
Masimo is a global medical technology company that produces industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity, automation, telehealth, and consumer solutions. Our mission is to improve patient outcomes, reduce the cost of care, take noninvasive monitoring to new sites and applications, and improve life. |
| SILVER |
|
LeanTaaS is the leading provider of AI-powered and cloud-based capacity management, staffing, and patient flow software and services for health systems. Our iQueue products for operating rooms, infusion centers, and inpatient units use Lean principles and AI/ML predictive and prescriptive analytics to forecast future demand based on historical data, recent pattern shifts, and real-time insights. They help staff and providers act quickly, confidently, and decisively in response to avoid operational bottlenecks before they happen. The result? Expensive assets are utilized better, hospital ROI improves, patient access increases, and clinicians work at the top of their license with reduced administrative burden. |
| EXHIBITOR |
.png)
| For more than 50 years, Edwards Lifesciences has been helping you make proactive clinical decisions and advance the care of surgical and acutely ill patients across the continuum of care. Through ongoing collaboration with clinicians, providing continuous education, and our dedication to purposeful innovation, Edwards continues to develop smart hemodynamic management solutions that enable proactive decision support. |
| EXHIBITOR |
| Irrimax Corporation is focused on reducing infections, healthcare costs and improving patient outcomes. Irrimax manufactures Irrisept Antimicrobial Wound Lavage, a single-use, manual, self-contained irrigation device comprised of 0.05% Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water for Irrigation, United States Pharmacopeia (USP). Visit www.irrisept.com to learn more or request a sample. |
| EXHIBITOR |
| Medasense is transforming pain management with its breakthrough technology that empowers clinicians to optimize and personalize pain control, significantly reducing the risk of pain or of overmedication. The company's flagship product, the PMD-200™, equipped with the NOL-Nociception Level Index®, leverages advanced artificial intelligence and a proprietary non-invasive sensor system. This unique platform provides objective monitoring and quantification of a patient’s pain response, making it an essential tool in operating room and critical care unit settings where patients cannot communicate their pain levels. The PMD-200 is the first and only monitor to be authorized by the FDA for pain measurement for anesthesiology. It has been used in over 100,000 surgeries worldwide, and is commercially available in the US, Europe, Canada, Latin America and Israel. |
| EXHIBITOR + Unrestricted Educational Grant |
| Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. |
| EXHIBITOR |
| At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. |
| EXHIBITOR |
| Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs nearly 12,000 employees worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Hematology and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centers across Europe and the US. Octapharma has 40 years of experience in patient care. |
| EXHIBITOR |
| Precare is a digital platform focused on personalized solutions to improve patient education and engagement. |
| EXHIBITOR |
| Renibus Therapeutics is dedicated to treating, improving, and extending patients’ lives by developing breakthrough products to prevent disease progression, improve outcomes and protect against organ damage in cardiorenal diseases. Renibus’ first-in-class lead program, RBT-1 (stannic protoporfin/iron sucrose), is a potent inducer of anti-inflammatory, antioxidant and iron-scavenging pathways. RBT-1 has finished its Phase 2 development in cardiac surgery and is currently being evaluated in a Phase 3 registration study to reduce the risk of postoperative complications following cardiothoracic surgery. |
| EXHIBITOR |
| Senzime, based in Uppsala, Sweden, is at the forefront of a global transformation in perioperative care, driven by the advanced TetraGraph® monitoring system. This pioneering technology exemplifies our commitment to improving patient safety, providing clinicians with real-time neuromuscular monitoring that ensures enhanced recovery. The TetraGraph® is the flagship of our solutions, including the ExSpiron® 2Xi, all meticulously engineered to reduce postoperative complications for over 100 million patients worldwide by supporting Enhanced Recovery After Surgery (ERAS) protocols. |